These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23828764)

  • 1. Psychosocial support and cognitive deficits in adults with schizophrenia.
    Dalagdi A; Arvaniti A; Papatriantafyllou J; Xenitidis K; Samakouri M; Livaditis M
    Int J Soc Psychiatry; 2014 Aug; 60(5):417-25. PubMed ID: 23828764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-perceived cognitive deficits and occupational outcome in persons with schizophrenia.
    Verdoux H; Monello F; Goumilloux R; Cougnard A; Prouteau A
    Psychiatry Res; 2010 Jul; 178(2):437-9. PubMed ID: 20478628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished humour perception in schizophrenia: relationship to social and cognitive functioning.
    Polimeni JO; Campbell DW; Gill D; Sawatzky BL; Reiss JP
    J Psychiatr Res; 2010 May; 44(7):434-40. PubMed ID: 19892368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivational deficits and cognitive test performance in schizophrenia.
    Fervaha G; Zakzanis KK; Foussias G; Graff-Guerrero A; Agid O; Remington G
    JAMA Psychiatry; 2014 Sep; 71(9):1058-65. PubMed ID: 25075930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial functioning and cognitive deficits are not associated with membrane-bound catechol-O-methyltransferase deoxyribonucleic acid methylation in siblings of patients with schizophrenia.
    Chen X; Liu W; Wang L; Tang J; Wang X; Han X; Stone WS; Tan L
    J Nerv Ment Dis; 2012 Nov; 200(11):941-5. PubMed ID: 23124177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is quality of life associated with cognitive impairment in schizophrenia?
    Alptekin K; Akvardar Y; Kivircik Akdede BB; Dumlu K; Işik D; Pirinçci F; Yahssin S; Kitiş A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):239-44. PubMed ID: 15694230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized and specific neurocognitive deficits in prodromal schizophrenia.
    Lencz T; Smith CW; McLaughlin D; Auther A; Nakayama E; Hovey L; Cornblatt BA
    Biol Psychiatry; 2006 May; 59(9):863-71. PubMed ID: 16325151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cognitive rehabilitation on social knowledge in patients with schizophrenia.
    Matsui M; Arai H; Yonezawa M; Sumiyoshi T; Suzuki M; Kurachi M
    Appl Neuropsychol; 2009 Jul; 16(3):158-64. PubMed ID: 20183166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
    Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
    J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.
    Fervaha G; Agid O; Foussias G; Remington G
    J Psychiatr Res; 2014 May; 52():50-6. PubMed ID: 24507885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-perceived cognitive functioning does not correlate with objective measures of cognition in schizophrenia.
    Johnson I; Tabbane K; Dellagi L; Kebir O
    Compr Psychiatry; 2011; 52(6):688-92. PubMed ID: 21296346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.